EUVIMEDEUVIMED entdecken
Crossref

APX2009 sensitizes hypoxic breast cancer cells to doxorubicin by increasing its accumulation and caspase-3/7-mediated apoptosis

Ísis Salviano Soares de Amorim, Daphne Pinheiro, Matheus da Silva Oliveira, Mariana Moreno de Sousa Rodrigues, Julia Silva José, Priscyanne Barreto Siqueira, Bruno Ricardo Barreto Pires, Adenilson de Souza da Fonseca, Andre Luiz Mencalha

Breast Cancer Research and Treatment · 2025

DOI: 10.1007/s10549-024-07512-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, 2025. Verfasst von Ísis Salviano Soares de Amorim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Biologia Do Câncer, Instituto de Biologia Roberto Alcântara Gomes, Universidade Do Estado Do Rio de Janeiro, Rio de Janeiro, RJ, Brazi…. Hauptthemen laut MEDLINE: Doxorubicin, Apoptosis, Caspase 3, Caspase 7. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The association of targeted therapy with chemotherapy is encouraged to increase the treatment efficiency, especially in hypoxic triple-negative breast cancer. The APE1 redox activity has stood out as a potential tumor target. However, the effect of the association of the APE1 redox inhibitors with doxorubicin in hypoxia still needs to be evidenced. Therefore, our objective was to investigate the effect of the APX2009 (APE1 inhibitor) on the sensitization of breast cancer cells to doxorubicin in normoxia and hypoxia. METHODS: The WST-1 assay was used to evaluate cell viability after APX2009 and doxorubicin application under normoxia and hypoxia conditions in the MCF-7 and MDA-MB-231 cells. Apoptosis was analyzed by annexin assay and detection of caspases-3/7 activity by luminescence-based assay. The clinical association between APE1 inhibition signature and doxorubicin sensitivity was evaluated by bioinformatics analyses. RESULTS: MDA-MB-231 and MCF-7 cell lines were more sensitive to APX2009 in normoxia than in hypoxia. Co-treatment with APX2009 and doxorubicin in hypoxia further decreased the viability of triple-negative MDA-MB-231 cells than treatment alone, which was accompanied by doxorubicin intracellular accumulation, and increase of apoptotic cells percentage, and caspases-3/7 activity. Moderate association was found between APE1 inhibition signature and doxorubicin sensitivity in the hypoxic basal subtype. CONCLUSION: The findings suggest that APX2009 sensitizes the MDA-MB-231 cells to doxorubicin in hypoxia by doxorubicin intracellular accumulation and caspases-3/7-mediated apoptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinApoptosisCaspase 3Caspase 7Breast NeoplasmsDNA-(Apurinic or Apyrimidinic Site) LyaseHumansFemaleCell Line, TumorMCF-7 CellsCell HypoxiaCell SurvivalDrug Resistance, NeoplasmAntibiotics, AntineoplasticAmidesPhthalic Acids

Stichwörter der Autor:innen

APE1ApoptosisBreast cancerDoxorubicinHypoxia

Substanzen

DoxorubicinCaspase 3Caspase 7DNA-(Apurinic or Apyrimidinic Site) LyaseAntibiotics, AntineoplasticAmidesPhthalic AcidsAPEX1 protein, humanCASP7 protein, humanCASP3 protein, human

Autor:innen und Institutionen

  • Laboratório de Biologia Do Câncer, Instituto de Biologia Roberto Alcântara Gomes, Universidade Do Estado Do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
  • Laboratório de Alimentos Funcionais, Instituto de Nutrição Josué de Castro, Universidade Federal Do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
  • Laboratório de Regulação E Expressão Gênica, Instituto de Biologia Roberto Alcântara Gomes, Universidade Do Estado Do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
  • Laboratório de Biofotônica, Instituto de Biologia Roberto Alcântara Gomes, Universidade Do Estado Do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
  • Laboratório de Biologia Do Câncer, Instituto de Biologia Roberto Alcântara Gomes, Universidade Do Estado Do Rio de Janeiro, Rio de Janeiro, RJ, Brazil. almencalha@yahoo.com.br.

Förderung

  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

de Amorim, Í. S. S., Pinheiro, D., da Silva Oliveira, M., de Sousa Rodrigues, M. M., José, J. S., Siqueira, P. B., Pires, B. R. B., de Souza da Fonseca, A., & Mencalha, A. L. (2025). APX2009 sensitizes hypoxic breast cancer cells to doxorubicin by increasing its accumulation and caspase-3/7-mediated apoptosis. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07512-6

Vancouver

de Amorim ÍSS, Pinheiro D, da Silva Oliveira M, de Sousa Rodrigues MM, José JS, Siqueira PB, et al. APX2009 sensitizes hypoxic breast cancer cells to doxorubicin by increasing its accumulation and caspase-3/7-mediated apoptosis. Breast Cancer Research and Treatment. 2025. doi:10.1007/s10549-024-07512-6

BibTeX
@article{deAmorim2025,
  author = {de Amorim, Ísis Salviano Soares and Pinheiro, Daphne and da Silva Oliveira, Matheus and de Sousa Rodrigues, Mariana Moreno and José, Julia Silva and Siqueira, Priscyanne Barreto and Pires, Bruno Ricardo Barreto and de Souza da Fonseca, Adenilson and Mencalha, Andre Luiz},
  title = {APX2009 sensitizes hypoxic breast cancer cells to doxorubicin by increasing its accumulation and caspase-3/7-mediated apoptosis},
  journal = {Breast Cancer Research and Treatment},
  year = {2025},
  doi = {10.1007/s10549-024-07512-6}
}
Kostenlos starten →